Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Hofseth Biocare ASA ( (HOFBF) ) has provided an announcement.
Bonafide Investment Fund – Best Catches I has transferred its shareholding in Hofseth Biocare ASA to Bonafide Investment Fund – HBC II as a contribution in kind, leaving Best Catches I with no remaining shares in the company. Following this restructuring, IFM Independent Fund Management AG will control 16.62% of the voting rights in Hofseth Biocare ASA, based on 395,081,030 outstanding shares, consolidating its position as a major shareholder and potentially increasing its influence over corporate governance.
The change in ownership structure reflects an internal reallocation within the Bonafide fund complex rather than a net exit of capital from Hofseth Biocare. For existing shareholders and the market, the clarified 16.62% voting stake held via IFM underscores a significant bloc in the shareholder base, which may shape future strategic decisions and investor dynamics around the company.
More about Hofseth Biocare ASA
Hofseth Biocare ASA is a Norwegian biotech and nutrition company focused on developing and producing marine-based ingredients and products. It operates in the health, nutrition, and pet care markets, leveraging sustainable use of salmon offcuts to create high-value proteins, lipids, and calcium for global customers.
Average Trading Volume: 170,857
Current Market Cap: NOK581.7M
Learn more about HOFBF stock on TipRanks’ Stock Analysis page.